Author(s): Salter SJ, Cook P, Davies JH, Armston AE
Abstract Share this page
Abstract BACKGROUND: Monitoring of treatment for patients diagnosed with congenital adrenal hyperplasia (CAH) can be performed by measuring the concentration of 17α-hydroxyprogesterone (17OHP) in bloodspots collected on filter papers. A method is described here for measuring 17OHP by liquid chromatography tandem mass spectrometry (LCMSMS). METHODS: 17OHP was extracted by liquid-liquid extraction and analysed by LCMSMS. The method was validated for sensitivity, specificity, linearity, recovery, ion suppression, precision and bias. RESULTS: The standard curve was linear from 0 to 400 nmol/L. Intra-assay \%CVs were <10 and inter-assay \%CVs were <15 over the range 10-200 nmol/L. Limit of quantitation was 6 nmol/L. No ion suppression was detected. The only interfering compound detected was deoxycorticosterone, an intermediate steroid with the same molecular weight as 17α-hydroxyprogesterone. The method was more accurate and precise than an existing radioimmunoassay. There was poor correlation between the two assays. CONCLUSIONS: We have developed a sensitive and specific assay suitable for quantitation of 17OHP in bloodspots. This method performs better than radioimmunoassay and allows smaller samples to be used. © The Author(s) 2014 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav.
This article was published in Ann Clin Biochem
and referenced in Journal of Molecular Biomarkers & Diagnosis